157 related articles for article (PubMed ID: 23937980)
1. Optimization of diarylazines as anti-HIV agents with dramatically enhanced solubility.
Bollini M; Cisneros JA; Spasov KA; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2013 Sep; 23(18):5213-6. PubMed ID: 23937980
[TBL] [Abstract][Full Text] [Related]
2. Extension into the entrance channel of HIV-1 reverse transcriptase--crystallography and enhanced solubility.
Bollini M; Frey KM; Cisneros JA; Spasov KA; Das K; Bauman JD; Arnold E; Anderson KS; Jorgensen WL
Bioorg Med Chem Lett; 2013 Sep; 23(18):5209-12. PubMed ID: 23899617
[TBL] [Abstract][Full Text] [Related]
3. Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility.
Frączek T; Kamiński R; Krakowiak A; Naessens E; Verhasselt B; Paneth P
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):9-16. PubMed ID: 29098886
[TBL] [Abstract][Full Text] [Related]
4. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
5. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
Jin X; Piao HR; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2021 Dec; 226():113868. PubMed ID: 34583311
[TBL] [Abstract][Full Text] [Related]
6. A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
Urano E; Miyauchi K; Kojima Y; Hamatake M; Ablan SD; Fudo S; Freed EO; Hoshino T; Komano J
ChemMedChem; 2016 Oct; 11(20):2320-2326. PubMed ID: 27634404
[TBL] [Abstract][Full Text] [Related]
7. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents.
Liu X; Chen P; Li X; Ba M; Jiao X; Guo Y; Xie P
Bioorg Med Chem Lett; 2018 Jun; 28(10):1699-1703. PubMed ID: 29699924
[TBL] [Abstract][Full Text] [Related]
9. Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Viira B; Selyutina A; García-Sosa AT; Karonen M; Sinkkonen J; Merits A; Maran U
Bioorg Med Chem; 2016 Jun; 24(11):2519-2529. PubMed ID: 27108399
[TBL] [Abstract][Full Text] [Related]
10. 2,6-Di(arylamino)-3-fluoropyridine Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
Sergeyev S; Yadav AK; Franck P; Michiels J; Lewi P; Heeres J; Vanham G; Ariën KK; Vande Velde CM; De Winter H; Maes BU
J Med Chem; 2016 Mar; 59(5):1854-68. PubMed ID: 26785139
[TBL] [Abstract][Full Text] [Related]
11. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
Huang B; Li C; Chen W; Liu T; Yu M; Fu L; Sun Y; Liu H; De Clercq E; Pannecouque C; Balzarini J; Zhan P; Liu X
Eur J Med Chem; 2015 Mar; 92():754-65. PubMed ID: 25626145
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Liu N; Qin B; Sun LQ; Yu F; Lu L; Jiang S; Lee KH; Xie L
Bioorg Med Chem Lett; 2014 Aug; 24(16):3719-23. PubMed ID: 25042339
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
[TBL] [Abstract][Full Text] [Related]
14. TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.
Azijn H; Tirry I; Vingerhoets J; de Béthune MP; Kraus G; Boven K; Jochmans D; Van Craenenbroeck E; Picchio G; Rimsky LT
Antimicrob Agents Chemother; 2010 Feb; 54(2):718-27. PubMed ID: 19933797
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
16. Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs.
Ding L; Pannecouque C; De Clercq E; Zhuang C; Chen FE
J Med Chem; 2021 Jul; 64(14):10297-10311. PubMed ID: 34197708
[TBL] [Abstract][Full Text] [Related]
17. Design of annulated pyrazoles as inhibitors of HIV-1 reverse transcriptase.
Sweeney ZK; Harris SF; Arora SF; Javanbakht H; Li Y; Fretland J; Davidson JP; Billedeau JR; Gleason SK; Hirschfeld D; Kennedy-Smith JJ; Mirzadegan T; Roetz R; Smith M; Sperry S; Suh JM; Wu J; Tsing S; Villaseñor AG; Paul A; Su G; Heilek G; Hang JQ; Zhou AS; Jernelius JA; Zhang FJ; Klumpp K
J Med Chem; 2008 Dec; 51(23):7449-58. PubMed ID: 19007201
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral evaluation of C-4-hydrazide derivatives of 2',3'-dideoxycytidine.
Boudou-Vivet V; Mathé C; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1029-32. PubMed ID: 11562952
[TBL] [Abstract][Full Text] [Related]
19. Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors.
Xu S; Song S; Sun L; Gao P; Gao S; Ma Y; Kang D; Cheng Y; Zhang X; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
Bioorg Med Chem; 2022 Jan; 53():116531. PubMed ID: 34890994
[TBL] [Abstract][Full Text] [Related]
20. Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors.
Han S; Sang Y; Wu Y; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2020 Jan; 185():111874. PubMed ID: 31735575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]